Registration Dossier

Administrative data

Description of key information

Limited information is available on the skin, eye and respiratory tract irritation potential of cadmium metal and cadmium compounds. In a study on patients with eczema, cadmium chloride caused skin irritation in 1.7% of the volunteers when applied at 2%. Based on single and repeated inhalation exposure studies, cadmium oxide fumes may be considered irritating to the respiratory tract. However, given the carcinogenic properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place at the workplace to prevent contact.Therefore, neither skin, eye nor respiratory tract irritation are expected to be an issue for human health and further testing is not considered necessary for these endpoints, in accordance with Annex XI (3) of the REACH directive. This is in line with the conclusions of the EU RAR (ECB, 2007).
No studies were located regarding corrosivity for humans or animals.However, if at all, significantexposure is expected to occur principally in occupational settings.Given the carcinogen properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place to prevent contact.Therefore, corrosivity is not expected to be an issue for human health and further testing is not considered necessary, in accordance withAnnex XI (3) of the REACH directive.This is in line with the conclusions of the EU RAR (ECB, 2007).

Key value for chemical safety assessment

Skin irritation / corrosion

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Eye irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Respiratory irritation

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed (not irritating)

Additional information

Limited information is available on the skin, eye and respiratory tract irritation potential of cadmium metal and cadmium compounds. In a study on patients with eczema, cadmium chloride caused skin irritation in 1.7% of the volunteers when applied at 2%. Based on single and repeated inhalation exposure studies, cadmium oxide fumes may be considered irritating to the respiratory tract. However, given the carcinogenic properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place at the workplace to prevent contact.Therefore, neither skin, eye nor respiratory tract irritation are expected to be an issue for human health and further testing is not considered necessary for these endpoints, in accordance with Annex XI (3) of the REACH directive. This is in line with the conclusions of the EU RAR (ECB, 2007).

At present, none of the cadmium substances covered in the present assessment is classified for irritation according to Directive 67/548/EEC.

No studies were located regarding corrosivity for humans or animals.However, if at all, significantexposure is expected to occur principally in occupational settings.Given the carcinogen properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place to prevent contact.Therefore, corrosivity is not expected to be an issue for human health and further testing is not considered necessary, in accordance withAnnex XI (3) of the REACH directive.This is in line with the conclusions of the EU RAR (ECB, 2007).

At present, none of the cadmium substances covered in the present assessment is classified for corrosivity in Annex I of Directive 67/548/EEC.

Justification for classification or non-classification

Limited information is available on the skin, eye and respiratory tract irritation potential of cadmium metal and cadmium compounds. However, given the carcinogenic properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place at the workplace to prevent contact.Therefore, neither skin, eye nor respiratory tract irritation are expected to be an issue for human health and further testing is not considered necessary for these endpoints, in accordance with Annex XI (3) of the REACH directive. This is in line with the conclusions of the EU RAR (ECB, 2007).

At present, none of the cadmium substances covered in the present assessment is classified for irritation according to Directive 67/548/EEC.

No studies were located regarding corrosivity for humans or animals.However, if at all, significantexposure is expected to occur principally in occupational settings.Given the carcinogen properties of cadmium metal and some of the cadmium compounds, risk reduction measures are in place to prevent contact.Therefore, corrosivity is not expected to be an issue for human health and further testing is not considered necessary, in accordance with Annex XI (3) of the REACH directive.This is in line with the conclusions of the EU RAR (ECB, 2007).

At present, none of the cadmium substances covered in the present assessment is classified for corrosivity in Annex I of Directive 67/548/EEC.